Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapy. [electronic resource]
Producer: 20200814Description: 48 p. digitalISSN:- 1559-131X
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- BRCA1 Protein -- genetics
- Carcinoma -- drug therapy
- Female
- Germ-Line Mutation
- Hereditary Breast and Ovarian Cancer Syndrome -- drug therapy
- Humans
- Leukemia, Myeloid, Acute -- chemically induced
- Middle Aged
- Oncogene Proteins, Fusion -- genetics
- Topoisomerase II Inhibitors -- adverse effects
- Translocation, Genetic
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.